These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. Ellis SG, Colombo A, Grube E, Popma J, Koglin J, Dawkins KD, Stone GW. J Am Coll Cardiol; 2007 Mar 13; 49(10):1043-51. PubMed ID: 17349883 [Abstract] [Full Text] [Related]
6. New drug-eluting stent platforms to prevent stent thrombosis. Kereiakes DJ. Rev Cardiovasc Med; 2007 Mar 13; 8 Suppl 1():S34-43. PubMed ID: 17401310 [Abstract] [Full Text] [Related]
7. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators. Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853 [Abstract] [Full Text] [Related]